To evaluate the clinical mechanism of Lian-Hua Qing-Wen capsule on systemic immune regulation of influenza patients
- Conditions
- influenza
- Registration Number
- ITMCTR2100005453
- Lead Sponsor
- Ruijin Hospital, Shanghai Jiaotong University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. Meet the influenza clinical diagnosis criteria of Influenza Diagnosis and Treatment Protocol (2020 Edition);
2.18 = age < 70;
3. Fever duration =48h, maximum axillary temperature =38.5?;
4. Pharyngeal swabs tested positive for influenza virus rapid antigen.
5. Signed the informed consent, and the informed consent process was in accordance with the provisions.
6. Flu patients who have received COVID-19 vaccine for more than a month.
1. Comply with the epidemic cold diagnosis and treatment plan (2020 edition) influenza clinical diagnosis criteria;
2.18 years old = age <70 years old;
3. The heating process is =48h, the highest underarm temperature = 38.5 ° C;
4. Positive antigen detection of throat swab influenza virus;
5. Sign the informed consent, the informed consent process meets the requirements;
6. Injection of neoguan vaccine patients more than 1 month of flu patients.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Inflammatory factors;Immune cell genus;
- Secondary Outcome Measures
Name Time Method